MAPK Signaling
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
A1947 MEK162 (ARRY-162, ARRY-438162)Target: MEKSummary: MEK1/2 inhibitor,potent and selective
-
A8304 FR 180204Target: ERKSummary: ERK inhibitor
-
A8313 RAF265Target: Raf|VEGFRSummary: Multiple intracellular kinases inhibitor
-
A8435 FurosemideTarget: Na /K /Cl- Symporters (NKCCs)|GABAA ReceptorsSummary: GABAA receptors antagonist
-
A8686 VX-745Target: p38Summary: P38α inhibitor,highly potent and selective
-
A8689 PD 169316Target: p38Summary: P38 MAPK inhibitor
-
B2227 BI-D18701 CitationTarget: p90 S6KSummary: P90 RSK inhibitor,ATP-competitive and cell-permeable
-
B1405 GW5074Summary: C-Raf inhibitor,potent and selective
-
B1267 RefametinibTarget: MEKSummary: MEK 1/ MEK 2 inhibitor
-
B1174 LGX818Target: RafSummary: RAF inhibitor,potent and selective